June 30, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people ...

The opioid crisis has made it even more urgent to come up with novel approaches to treating suffering. Finally there’s ...

Neuropathic corneal pain is a condition that results in pain and sensitivity of the eyes, ... as measured by the visual analog scale (VAS), were also seen in patients treated with urcosimod.

When the project was set to scale up and conduct in vivo, ... Two of these molecules are undergoing preclinical evaluation for reversing all the key parameters for peripheral neuropathic pain, ...

On a 0–10 pain scale, the hydrodissection group reported an average pain reduction of 4 points, compared to 3 points for those on opioids alone - a significant difference considered clinically ...

Pregabalin demonstrated better pain outcomes, with a significantly lower global VAS score (standardized mean difference [SMD], -0.47; 95% CI, -0.74 to -0.19), with significant improvements ...

This 352-person trial, dubbed Study 1133 and conducted in the U.S., found that condoliase (a single injection of 1 mL at varying concentrations) did improve average leg pain from baseline to week ...

Among patients with rheumatoid arthritis (RA), persisting and neuropathic pain types were common, often accompanied by pain catastrophizing and a higher tender joint count, according to study results ...

Vertex passes neuropathic pain test, ... After 12 weeks of treatment, mean scores on the 11-point Numeric Pain Rating Scale (NPRS) fell by between 2.11 and 2.26 in the three VX-548 arms.

It is different from neuropathic pain, which involves damage to the nervous system. ... Seven of the questions ask them to rate different sensations from their pain on a scale from 0 to 5.

About the VX-548 Phase 2 Study in Neuropathic Pain The Phase 2 study will be a randomized, double-blind, active-controlled, dose-ranging study evaluating the efficacy and safety of VX-548 in ...